Wrocław, Poland

Tadeusz Wilusz

This inventor holds 1 USPTO granted patent. Top assignee: Regen Therapeutics Plc. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadeusz Wilusz. Retrieved from https://idiyas.com/inventor/tadeusz-wilusz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tadeusz Wilusz: Innovator in Peptide Purification

Introduction

Tadeusz Wilusz is a notable inventor based in Wrocław, Poland. He has made significant contributions to the field of peptide purification, particularly through his innovative methods involving colostrum. His work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Tadeusz Wilusz holds a patent for the purification of peptides from colostrum. The invention relates to a method that involves the addition of an alcohol, such as methanol or ethanol, to a mixture to create an alcohol phase rich in peptides, along with a precipitate. This peptide-rich alcohol phase is then recovered and subjected to further fractionation. This method is particularly useful for purifying colostrinin from colostrum. He has 1 patent to his name.

Career Highlights

Wilusz is associated with Regen Therapeutics Plc, where he applies his expertise in peptide purification. His work at the company has positioned him as a key player in advancing therapeutic solutions derived from colostrum.

Collaborations

Tadeusz Wilusz collaborates with notable colleagues, including Antoni Polanowski and Marian L. Kruzel. Their combined efforts contribute to the innovative research and development at Regen Therapeutics Plc.

Conclusion

Tadeusz Wilusz is a pioneering inventor whose work in peptide purification from colostrum has the potential to impact the biotechnology sector significantly. His contributions, along with his collaborations, highlight the importance of innovation in advancing therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…